• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

20/05/2026 16:24

Glenmark Pharma. - Press Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2026, titled ""Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors"".